Astera Labs, Inc. ALAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 153.67% | 104.45% | 93.40% | 91.77% | 103.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 153.67% | 104.45% | 93.40% | 91.77% | 103.89% |
| Cost of Revenue | 196.09% | 126.12% | 82.91% | 80.39% | 117.24% |
| Gross Profit | 140.46% | 97.56% | 96.92% | 95.77% | 100.07% |
| SG&A Expenses | 75.37% | 59.79% | 9.41% | -8.49% | -10.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 131.69% | 99.24% | 66.40% | 44.46% | 43.60% |
| Operating Income | 223.17% | 124.39% | 447.92% | 46,398.61% | 722.82% |
| Income Before Tax | 187.20% | 102.97% | 238.05% | 637.39% | 3,216.57% |
| Income Tax Expenses | 137.45% | -8,875.54% | 31.74% | 342.19% | -352.39% |
| Earnings from Continuing Operations | 100.79% | 198.89% | 152.40% | 82.02% | 1,299.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.79% | 198.89% | 152.40% | 82.02% | 1,299.97% |
| EBIT | 223.17% | 124.39% | 447.92% | 46,398.61% | 722.82% |
| EBITDA | 223.71% | 126.34% | 428.15% | 6,143.65% | 806.75% |
| EPS Basic | 93.05% | 186.85% | 141.23% | 71.67% | 1,224.38% |
| Normalized Basic EPS | 176.16% | 94.78% | 223.08% | 596.17% | 3,020.00% |
| EPS Diluted | 98.00% | 186.21% | 144.44% | 83.67% | 1,100.00% |
| Normalized Diluted EPS | 181.88% | 97.13% | 232.41% | 622.02% | 2,791.25% |
| Average Basic Shares Outstanding | 4.00% | 4.20% | 4.62% | 6.01% | 6.76% |
| Average Diluted Shares Outstanding | 1.91% | 2.94% | 1.71% | 2.04% | 15.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |